Innovative Clinical Science. Improved Patient Care.
We focus our research and development practice on discovering and developing new medicines for unmet medical needs. Right now, the Genentech Research and Early Development pipeline has more than 30 new molecular entities in clinical development.
Journeys: Bob Cohen
Clinical scientist Bob Cohen chose to shift from practicing oncology to researching new treatment options for cancer patients.
How to Get Into the Brain
Learn how Genentech scientists developed a new way to get medicines through the blood-brain barrier.Gene Expressions
This video series explores ongoing research by our scientists in a variety of focus areas. Watch it on YouTube.A Patient-centric Approach
Here's how we put patients at the heart of everything we do.Understanding Reimbursement
Information reimbursement denials and appeals as well as billing and coding.Our Founders
Bob Swanson & Herb Boyer started the company that launched an industry.Living with Rheumatoid Arthritis
Brenda and Elaine discuss their diagnosis and the impact of chronic disease on their daily lives.Help Your Patients
Genentech Access Solutions offers your patients coverage support, assistance, other useful information.Medical Information for HCPs
This convenient resource offers scientific and clinical information for US healthcare providers.
Understanding Antibody-Drug Conjugates
ADCs combine three components to provide a unique treatment option.Approvals Timeline
A look at our approvals past and present.
